Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Amber L Winter"'
Autor:
Antonella Borgatti, Amber L Winter, Kathleen Stuebner, Ruth Scott, Christopher P Ober, Kari L Anderson, Daniel A Feeney, Daniel A Vallera, Joseph S Koopmeiners, Jaime F Modiano, Jerry Froelich
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172651 (2017)
Positron Emission Tomography-Computed Tomography (PET-CT) is routinely used for staging and monitoring of human cancer patients and is becoming increasingly available in veterinary medicine. In this study, 18-fluorodeoxyglucose (18FDG)-PET-CT was use
Externí odkaz:
https://doaj.org/article/f1483c8f3fc04647845ddb2059e0f23d
Autor:
Rose H. Dicovitsky, Jill T. Schappa, Ashley J. Schulte, Haeree P. Lang, Ellen Kuerbitz, Sarah Roberts, Taylor A. DePauw, Mitzi Lewellen, Amber L. Winter, Kathy Stuebner, Michelle Buettner, Kelly Reid, Kelly Bergsrud, Sara Pracht, Andrea Chehadeh, Caitlin Feiock, M. Gerard O’Sullivan, Tim Carlson, Alexandra R. Armstrong, Danielle Meritet, Michael S. Henson, Brenda J. Weigel, Jaime F. Modiano, Antonella Borgatti, Daniel A. Vallera
Publikováno v:
Toxins, Vol 16, Iss 9, p 376 (2024)
EGFR-targeted therapies are efficacious, but toxicity is common and can be severe. Urokinase type plasminogen activator receptor (uPAR)-targeted drugs are only emerging, so neither their efficacy nor toxicity is fully established. Recombinant eBAT wa
Externí odkaz:
https://doaj.org/article/6505ce6cd7b5471f92672f457ebc37f6
Autor:
Daniel A. Vallera, Jaime F. Modiano, Kristy Pilbeam, Felix Oh, Kerstin Lindblad-Toh, Matthew Breen, Michael S. Henson, Jillian Walz, Jerry Froelich, Jong-Hyuk Kim, Colleen L. Forster, Stephen Schmechel, Jonathan C. Henriksen, Anthony E. Rizzardi, Deborah Todhunter, Kathleen Stuebner, Amber L. Winter, Aaron L. Sarver, Joseph S. Koopmeiners, Antonella Borgatti
Detailed Methods for Immunohistochemistry Detailed Description of the Canine Clinical Study eBAT Pharmacokinetics and Neutralizing Antibody Assays Supplementary Table 1. Correlation between patient covariates and death Supplementary Table 2: Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a4aa52c0607ee0942297b84a938356
https://doi.org/10.1158/1535-7163.22505770
https://doi.org/10.1158/1535-7163.22505770
Autor:
Daniel A. Vallera, Jaime F. Modiano, Kristy Pilbeam, Felix Oh, Kerstin Lindblad-Toh, Matthew Breen, Michael S. Henson, Jillian Walz, Jerry Froelich, Jong-Hyuk Kim, Colleen L. Forster, Stephen Schmechel, Jonathan C. Henriksen, Anthony E. Rizzardi, Deborah Todhunter, Kathleen Stuebner, Amber L. Winter, Aaron L. Sarver, Joseph S. Koopmeiners, Antonella Borgatti
Sarcomas differ from carcinomas in their mesenchymal origin. Therapeutic advancements have come slowly, so alternative drugs and models are urgently needed. These studies report a new drug for sarcomas that simultaneously targets both tumor and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a17472aa6c47bead566c16a06a42417
https://doi.org/10.1158/1535-7163.c.6538177.v1
https://doi.org/10.1158/1535-7163.c.6538177.v1
Publikováno v:
J Am Vet Med Assoc
OBJECTIVE To identify physical examination and perioperative CBC variables in dogs with splenic hemangiosarcoma (HSA) that could aid in predicting progression-free interval (PFI) and overall survival time (OST) in affected dogs. ANIMALS 70 client-own
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da05c800c620cfe64b9cdb060ce17e84
https://doi.org/10.2460/javma.258.6.630
https://doi.org/10.2460/javma.258.6.630
Autor:
Kathleen Stuebner, Elizabeth Taras, Daniel A. Vallera, Deborah A. Todhunter, Alison R Masyr, Antonella Borgatti, Joseph S. Koopmeiners, Jaime F. Modiano, Aaron Rendhal, Ann M. Fieberg, Amber L. Winter
Publikováno v:
Vet Comp Oncol
We previously reported that eBAT, an EGF-targeted angiotoxin, was safe and it improved the overall survival for dogs with splenic haemangiosarcoma when added to the standard of care in a single cycle of three administrations in the minimal residual d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4030f384856d304b2ce9982f34d40d0d
https://doi.org/10.1111/vco.12590
https://doi.org/10.1111/vco.12590
Autor:
Kelly Bergsrud, Shruthi Naik, Ingrid Cornax, Gerard O'Sullivan, Jaime F. Modiano, Stephen J. Russell, Gary Cutter, Joseph S. Koopmeiners, Andrea Chehadeh, Donna Groschen, Sara Pracht, Amber L. Winter, Kathleen Stuebner, Alexandru-Flaviu Tabaran, Lauren J. Mills, Kelly M. Makielski, Michael A. Farrar, Milcah C. Scott, Aishwarya Sathyanarayan, Aaron L. Sarver, Michael S. Henson
Publikováno v:
Cancer Research. 81:1747-1747
The goal of this study was to evaluate safety, efficacy, and immunological activity of Vesicular Stomatitis Virus (VSV) expressing a species relevant (canine) interferon-beta (IFN-β) and the sodium iodide symporter (NIS), henceforth called VSV, in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdb23998048abc324c720dd017d51f6e
https://doi.org/10.1158/1538-7445.am2021-1747
https://doi.org/10.1158/1538-7445.am2021-1747
Autor:
Jillian Zientek Walz, Anthony E. Rizzardi, Joseph S. Koopmeiners, Amber L. Winter, Matthew Breen, Colleen L. Forster, Jaime F. Modiano, Antonella Borgatti, Kathleen Stuebner, Jong Hyuk Kim, Deborah A. Todhunter, Daniel A. Vallera, Michael S. Henson, Stephen C. Schmechel, Jerry W. Froelich, Jonathan Henriksen, Felix Oh, Kristy Pilbeam, Aaron L. Sarver, Kerstin Lindblad-Toh
Publikováno v:
Molecular Cancer Therapeutics. 16:956-965
Sarcomas differ from carcinomas in their mesenchymal origin. Therapeutic advancements have come slowly, so alternative drugs and models are urgently needed. These studies report a new drug for sarcomas that simultaneously targets both tumor and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c502a21f17b4cf1ec595ea339842a3
https://doi.org/10.1158/1535-7163.mct-16-0637
https://doi.org/10.1158/1535-7163.mct-16-0637
Autor:
Amber L. Winter, Una Yoon, Antonella Borgatti, Emily Greengard, Michael S. Henson, Kathleen Stuebner, Jaime F. Modiano, Daniel A. Saltzman, Vicki L. Wilk, Sara E. Fritz, Lance B. Augustin
Publikováno v:
Veterinary Medicine and Science. 2:179-190
We conducted a prospective phase I study to evaluate safety of an orally administered Salmonella encoding IL-2 (SalpIL2) in combination with amputation and adjuvant doxorubicin for canine appendicular osteosarcoma. Efficacy was assessed as a secondar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86d320b862c6a3368ed1a66bae71620a
https://doi.org/10.1002/vms3.32
https://doi.org/10.1002/vms3.32
Autor:
Sara E, Fritz, Michael S, Henson, Emily, Greengard, Amber L, Winter, Kathleen M, Stuebner, Una, Yoon, Vicki L, Wilk, Antonella, Borgatti, Lance B, Augustin, Jaime F, Modiano, Daniel A, Saltzman
Publikováno v:
Veterinary Medicine and Science
We conducted a prospective phase I study to evaluate safety of an orally administered Salmonella encoding IL‐2 (SalpIL2) in combination with amputation and adjuvant doxorubicin for canine appendicular osteosarcoma. Efficacy was assessed as a second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2f561b90b804406296d6d2a73202f7e
https://pubmed.ncbi.nlm.nih.gov/29067193
https://pubmed.ncbi.nlm.nih.gov/29067193